Clinical trial
Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema
NCT00387582 · Rocky Mountain Retina Consultants, Other · Completed
Key facts
| NCT number | NCT00387582 |
|---|---|
| Title | Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema |
| Official title | Lucentis in the Treatment of Macular Edema - A Phase II, Single Center, Randomized Study to Evaluate the Efficacy of Ranibizumab Versus Focal Laser Treatment in Subjects With Diabetic Macular Edema |
| Lead sponsor | Rocky Mountain Retina Consultants, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetic Retinopathy, Diabetic Macular Edema |
| Intervention type | Drug, Procedure |
| Interventions | Ranibizumab (Lucentis), Argon Laser |
| Enrollment | 49 |
| Start date | Jul 1, 2006 |
| Primary completion | Feb 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Oct 13, 2006 |
| Last update posted | May 6, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: